FOLD R&D Expenses
Amicus Therapeutics Inc · R&D Expenses
FOLD R&D Expenses
Latest reported$23.74Mperiod ending
FOLD Quarterly R&D Expenses ($0.00 → $23.74M)
Quarterly R&D Expenses
High-resolution chart · PNG
FOLD r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 23,741,000 | |
| 23,415,000 | |
| 60,848,000 | |
| 27,839,000 | |
| 30,190,000 | |
| 26,160,000 | |
| 24,683,000 | |
| 28,329,000 | |
| 35,029,000 | |
| 40,704,000 | |
| 35,149,000 | |
| 41,499,000 | |
| 63,871,000 | |
| 52,970,000 | |
| 78,319,000 | |
| 81,517,000 | |
| 85,596,000 | |
| 59,333,000 | |
| 63,003,000 | |
| 64,117,000 | |
| 79,293,000 | |
| 70,419,000 | |
| 69,611,000 | |
| 89,120,000 | |
| 91,912,000 | |
| 58,892,000 | |
| 70,981,000 | |
| 64,593,000 | |
| 57,217,000 | |
| 138,227,000 | |
| 34,660,000 | |
| 40,798,000 | |
| 45,808,000 | |
| 40,641,000 | |
| 31,985,000 | |
| 30,876,000 | |
| 30,630,000 | |
| 32,457,000 | |
| 18,281,000 | |
| 23,425,000 | |
| 22,625,000 | |
| 20,971,000 | |
| 17,234,000 | |
| 16,113,000 | |
| 15,605,000 | |
| 12,049,000 | |
| 9,978,000 | |
| 9,992,000 | |
| 9,120,000 | |
| 10,110,000 | |
| 10,725,000 | |
| 11,989,000 | |
| 11,047,000 | |
| 11,499,000 | |
| 13,723,000 | |
| 14,004,000 | |
| 14,401,000 | |
| 13,711,000 | |
| 11,618,000 | |
| 11,125,000 | |
| 13,154,000 | |
| 8,862,000 | |
| 8,137,000 | |
| 8,889,000 | |
| 10,127,000 | |
| 12,609,000 | |
| 13,470,000 | |
| 11,875,000 | |
| 13,775,000 | |
| 8,200,000 | |
| 8,848,000 | |
| 6,941,000 | |
| 9,670,000 | |
| 7,537,000 | |
| 6,783,000 | |
| 7,085,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |